,i  #aaith ,,congress  #b;d ,session    
,h4 ,r4 #hfcj  ,,in ,,the ,,house ,,of  
,,representatives  ,april #cj1 #bjbf,mr4
 ,rulli 7for himself and ,mrs4          
,harshbarger7 introduced the following  
bill2 which was referred to the         
,committee on ,energy and ,commerce  ,a 
,,bill  ,to amend the ,public ,health   
,service ,act to prohibit treatment of a
 biologic as a biological product based 
solely on the presence of a protein that
 is a clinically inactive component in  
such biologic1 and for other purposes4  
#a4 ,short title  ,this ,act may be     
cited as the ,protecting ,equal ,access 
to ,thyroid ,act of #bjbf or the ,,peat 
,act of #bjbf4  #b4 ,prohibition with   
respect to treatment of proteins in     
biologics  7a7 ,in general ,section     
#cea7;i77#a7 of the ,public ,health     
,service ,act 7#db ,u4,s4,c4            
#bfb7;i77#a77 is amended-- 7#a7 by      
striking ,the term and inserting the    
following3  7,a7 ,the term  2 and  7#b7 
by adding at the end the following3     

7,b7 ,a biologic described in           
subparagraph 7,a7 may not be treated as 
a biological product based solely on the
 presence of a protein that is a        
clinically inactive component in such   
biologic4  4  7b7 ,technical correction 
,section #cea7;i77#a7 of the ,public    
,health ,service ,act 7#db ,u4,s4,c4    
#bfb7;i77#a77 is amended in subparagraph
 7,a71 as designated by subsection      
7a77#a71 by striking protein 1 and      
inserting protein14